GGAUF — NeuroMind AI Cashflow Statement
0.000.00%
FinancialsHighly SpeculativeMid Cap
- $1.23bn
- $1.23bn
Annual cashflow statement for NeuroMind AI, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | |
Standards: | — | USG | USG | USG |
Status: | fx Preliminary | Final | Final | Final |
Net Income/Starting Line | — | -0.109 | 0.338 | 0.421 |
Non-Cash Items | — | -0.001 | -3.63 | -1.66 |
Unusual Items | ||||
Changes in Working Capital | — | 0.077 | 2.4 | 0.168 |
Change in Prepaid Expenses | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Payable / Accrued Expenses | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | — | -0.033 | -0.896 | -1.07 |
Other Investing Cash Flow Items | — | -257 | -1.41 | 265 |
Other Investing Cash Flow | ||||
Cash from Investing Activities | — | -257 | -1.41 | 265 |
Financing Cash Flow Items | — | -2.95 | 0 | — |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | — | 259 | 2.3 | -264 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | — | 2.33 | 0 | 0 |